Appeal No. 95-0155
Application No. 07/890,335
D. Collen, "Synergism of Tissue-Type Plasminogen Activator
(t-PA) and Single-Chain Urokinase-Type Plasminogen Activator
(scu-PA) on Clot Lysis In Vitro and a Mechanism for this
Effect," 57 Thrombosis and Haemostasis no. 3, 373 (1987).
THE ISSUE
As stated in the Examiner's Answer, page 2, section (4),
the previously entered rejections under 35 U.S.C. § 112, first
paragraph, and under 35 U.S.C. § 103 over the Reich et al.
reference, have been withdrawn.
The sole issue on appeal is whether the examiner erred in
rejecting claims 69, 70, 72 through 78, 80 through 84, 87
through 90 and 92 through 96 under 35 U.S.C. § 103 as
unpatentable over European Patent Application 0 041 766.
DELIBERATIONS
Our deliberations in this matter have included evaluation
and review of the following materials: (1) the instant speci-
fication, including all of the claims on appeal; (2)
applicant's Appeal Brief, the Reply Brief, and the
Supplemental Reply Brief; (3) the Examiner's Answer; and (4)
the above-cited references relied on by the examiner.
On consideration of the record, including the above-
listed materials, we reverse the examiner's rejection under
35 U.S.C. § 103.
-4-
Page: Previous 1 2 3 4 5 6 7 8 Next
Last modified: November 3, 2007